Your browser doesn't support javascript.
loading
[Evaluation of the dose-effect relationship of perindopril in the treatment of arterial hypertension]. / Evaluation de la relation dose-effet du perindopril dans le traitement de l'hypertension artérielle.
Luccioni, R; Frances, Y; Gass, R; Gilgenkrantz, J M.
Afiliação
  • Luccioni R; Service de médecine interne et urgences, CHU Nord, Cedex 15.
Arch Mal Coeur Vaiss ; 82 Spec No 1: 43-50, 1989 May.
Article em Fr | MEDLINE | ID: mdl-2505712
To evaluate the dose-effect relationship of antihypertensive drugs is essential to a rational determination of their effective dosage. Two double-blind and strictly controlled trials have demonstrated the effectiveness of perindopril 4 mg orally in the treatment of mild to moderate arterial hypertension (100 less than DAP less than 120 mmHg). The drug remained effective 24 hours after the last dose. The 2 mg dose proved insufficient to obtain a significant reduction of blood pressure. In case where the 4 mg dose was not sufficiently active, a better antihypertensive effect could be achieved with an 8 mg dose without major untoward reactions. The antihypertensive activity of perindopril was parallel to the percentage of angiotensin-converting enzyme inhibition induced by the compound. This study also illustrates clearly the value of semi-automatic blood pressure recording with the Dinamap system in the determination of dose-effect relationship, compared with the conventional sphygmomanometric method.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Hipertensão / Indóis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged Idioma: Fr Ano de publicação: 1989 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Hipertensão / Indóis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged Idioma: Fr Ano de publicação: 1989 Tipo de documento: Article